Unived Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-10-2024
- Paid Up Capital ₹ 2.47 M
as on 06-10-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue -0.55%
(FY 2023)
- Profit 29.47%
(FY 2023)
- Ebitda 16.24%
(FY 2023)
- Net Worth 30.20%
(FY 2023)
- Total Assets 27.83%
(FY 2023)
About Unived Healthcare Products
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.47 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Unived Healthcare Products Private Limited India is Amit Mehta as CEO. Amit Mehta and Monica Ugalde serve as directors at the Company.
- CIN/LLPIN
U24297MH2012PTC237326
- Company No.
237326
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Unived Healthcare Products Private Limited offer?
Unived Healthcare Products Private Limited offers a wide range of products and services, including Health Food & Drinks, Healthy Snacks, Popular Category, Mind Care, Immunity Boosters, Antioxidant Supplements, Vitamin C, Health Conditions, Kidney Care, Heart Care.
Who are the key members and board of directors at Unived Healthcare Products?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Mehta  | CEO | 14-Mar-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monica Ugalde  | Director | 16-Dec-2019 | Current |
| Amit Mehta | Director and Ceo | Current |
Financial Performance of Unived Healthcare Products.
Unived Healthcare Products Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.55% decrease. The company also saw a substantial improvement in profitability, with a 29.47% increase in profit. The company's net worth Soared by an impressive increase of 30.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unived Healthcare Products?
In 2023, Unived Healthcare Products had a public holding of 2.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unived Healthcare Products?
Unived Healthcare Products has a workforce of 8 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unived Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unived Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
